Trend of clinical trials of new drugs for rare diseases in China in recent 10 years

被引:0
|
作者
Ai Peng
Xue Fan
Linling Zou
Huan Chen
Jin Xiang
机构
[1] Sichuan University,Department of Neurology, West China Hospital
[2] Sichuan University,Clinical Trial Center, West China Hospital
[3] Sichuan University,NMPA Key Laboratory for Clinical Research and Evaluation of Innovative Drug, West China Hospital
[4] Sichuan University,Key Laboratory of Drug Targeting and Drug Delivery Systems, West China School of Pharmacy
关键词
Clinical trials; Rare disease; Development; China;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Innovative methodologies for rare diseases clinical trials
    Nabbout, Rima
    Hilgers, Ralf-Dieter
    ORPHANET JOURNAL OF RARE DISEASES, 2024, 19 (01)
  • [22] Clinical trials in rare diseases: a review of practice
    Stuart Bell
    Paula Williamson
    Simon Day
    Keith Wheatley
    John Whitehead
    Catrin Tudur Smith
    Trials, 14 (Suppl 1)
  • [23] Alternative designs for clinical trials in rare diseases
    Abrahamyan, Lusine
    Feldman, Brian M.
    Tomlinson, George
    Faughnan, Marie E.
    Johnson, Sindhu R.
    Diamond, Ivan R.
    Gupta, Samir
    AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS, 2016, 172 (04) : 313 - 331
  • [24] The problems of clinical trials and registries in rare diseases
    Luisetti, Maurizio
    Campo, Ilaria
    Scabini, Roberta
    Zorzetto, Michele
    Kadija, Zamir
    Mariani, Francesca
    Ferrarotti, Ilaria
    RESPIRATORY MEDICINE, 2010, 104 : S42 - S44
  • [25] Room for improvement in clinical trials for rare diseases
    Anne Musters
    Sander W. Tas
    Nature Reviews Rheumatology, 2020, 16 : 131 - 132
  • [26] Ethical aspects of clinical trials in rare diseases
    Hasford, Joerg
    Koch, Armin
    BUNDESGESUNDHEITSBLATT-GESUNDHEITSFORSCHUNG-GESUNDHEITSSCHUTZ, 2017, 60 (05) : 556 - 562
  • [27] Room for improvement in clinical trials for rare diseases
    Musters, Anne
    Tas, Sander W.
    NATURE REVIEWS RHEUMATOLOGY, 2020, 16 (03) : 131 - 132
  • [28] Regulatory Considerations for Developing Drugs for Rare Diseases: Orphan Designations and Early Phase Clinical Trials
    Pariser, Anne R.
    Xu, Kui
    Milto, John
    Cote, Timothy R.
    DISCOVERY MEDICINE, 2011, 11 (59) : 367 - 375
  • [29] Recent clinical trials in valvular heart diseases
    Goel, Sunny
    Ro, Richard
    Lerakis, Stamatios
    Khera, Sahil
    CURRENT OPINION IN CARDIOLOGY, 2020, 35 (04) : 313 - 318
  • [30] Orphandev, French Clinical Trials Network dedicated to Orphan drugs and therapeutics development for rare diseases
    Yolande Adjibi
    Joëlle Micallef
    Olivier Blin
    Orphanet Journal of Rare Diseases, 5 (Suppl 1)